Cargando…
Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future?
Autores principales: | Hu, Kai, Ertl, Georg, Nordbeck, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540617/ https://www.ncbi.nlm.nih.gov/pubmed/33027194 http://dx.doi.org/10.1097/FJC.0000000000000886 |
Ejemplares similares
-
Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022) -
Direct oral anticoagulants in extremely obese patients: OK to use?
por: Moll, Stephan, et al.
Publicado: (2018) -
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022) -
Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates
por: Schaefer, Jordan K., et al.
Publicado: (2023) -
Heart failure classification in clinical practice: time to redefine?
por: Hu, Kai, et al.
Publicado: (2022)